Table 3.
Mean | SD | Minimum | Maximum | Percentiles |
|||
---|---|---|---|---|---|---|---|
25 | Median | 75 | |||||
First evaluation (at diagnosis) | |||||||
PLV (log10) | 4.73 | 1.16 | 1.00 | 6.99 | 4.09 | 4.88 | 5.56 |
CD4 (cells/mm3) | 276 | 320 | 4 | 2140 | 56 | 168 | 334 |
CD8 (cells/mm3) | 966.9 | 587.6 | 51 | 2556 | 458 | 854 | 1345 |
Evaluation before introduction of new drugs | |||||||
PVL (log10) | 3.67 | 1.65 | 1.00 | 6.00 | 2.41 | 4.30 | 4.93 |
CD4 (cells/mm3) | 377 | 274 | 2 | 1300 | 101 | 242 | 429 |
CD8 (cells/mm3) | 938.8 | 599.2 | 108 | 2839 | 514 | 784 | 1234 |
Evaluation after 6 months under new drugs regimen | |||||||
PVL (log10) | 1.73 | 1.31 | 1.00 | 5.64 | 1.00 | 1.00 | 1.99 |
CD4 (cells/mm3) | 394.2 | 247.7 | 19 | 1270 | 212 | 338 | 530 |
CD8 (cells/mm3) | 1145.8 | 590.4 | 72 | 3018 | 761 | 1065 | 1375 |
Evaluation after 12 months under new drugs regimen | |||||||
PVL (log10) | 1.81 | 1.44 | 1.00 | 5.29 | 1.00 | 1.00 | 2.54 |
CD4 (cells/mm3) | 448.0 | 272.9 | 2 | 1592 | 295 | 398 | 569 |
CD8 (cells/mm3) | 1263.6 | 601.0 | 133 | 2958 | 782 | 1182 | 1777 |
p < 0.05 for comparisons between CD4 and viral load at baseline (time of regimen change) and either 6 months/12 months values.